Non–Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice Experiment
Background. There has been much innovation in the treatment of non–small cell lung cancer (NSCLC) in recent years. In particular, use of immuno-oncology (IO) therapies has been growing. Methods. Patients with NSCLC in the United States were surveyed online using a discrete choice experiment to elici...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-05-01
|
| Series: | MDM Policy & Practice |
| Online Access: | https://doi.org/10.1177/2381468320922208 |